Eyebright Medical Technology (Beijing) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000041J5
CNY
61.38
1.23 (2.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
424.49
352.36
331.41
385.02
370.48
308.97
279.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
424.49
352.36
331.41
385.02
370.48
308.97
279.37
Raw Material Cost
161.49
141.03
143.70
156.27
132.06
100.43
115.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.90
6.86
5.76
6.16
4.23
4.57
5.62
Selling and Distribution Expenses
106.19
92.96
86.57
78.18
97.38
78.02
92.40
Other Expenses
1.44
1.61
1.94
2.00
1.81
1.26
2.00
Total Expenditure (Excl Depreciation)
287.03
256.93
255.47
260.57
251.81
195.65
233.54
Operating Profit (PBDIT) excl Other Income
137.5
95.39999999999999
75.9
124.5
118.69999999999999
113.3
45.8
Other Income
8.42
12.48
5.77
6.38
6.88
6.48
8.97
Operating Profit (PBDIT)
187.25
148.68
113.75
169.95
159.64
153.84
81.69
Interest
4.90
6.86
5.76
6.16
4.23
4.57
5.62
Exceptional Items
-0.44
0.54
0.10
0.15
0.02
-0.12
0.05
Gross Profit (PBDT)
263.00
211.33
187.70
228.75
238.42
208.53
163.90
Depreciation
41.55
41.55
38.76
38.76
34.04
34.04
25.55
Profit Before Tax
140.36
100.80
69.32
125.18
121.39
115.10
50.57
Tax
23.42
11.26
-13.76
20.40
20.71
16.67
8.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
120.75
92.56
70.81
109.55
105.14
102.90
52.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
120.75
92.56
70.81
109.55
105.14
102.90
52.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.68
-2.74
12.23
-4.68
-4.43
-4.44
-9.61
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
117.07
89.81
83.04
104.87
100.71
98.47
42.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,789.34
2,448.03
2,409.50
2,330.29
2,255.08
2,215.15
2,129.63
Earnings per share (EPS)
0.63
0.49
0.37
0.58
0.56
0.54
0.27
Diluted Earnings per share
0.63
0.49
0.37
0.58
0.56
0.54
0.27
Operating Profit Margin (Excl OI)
32.34%
26.86%
20.89%
32.42%
32.05%
36.68%
16.88%
Gross Profit Margin
42.85%
40.4%
32.61%
42.58%
41.95%
48.27%
27.25%
PAT Margin
28.45%
26.27%
21.37%
28.45%
28.38%
33.31%
18.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 20.46% vs 6.34% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 30.40% vs 8.19% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 31.28% vs 26.11% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -28.99% vs 18.97% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Eyebright Medical Technology (Beijing) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
424.49
0
424.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
424.49
0
424.49
Raw Material Cost
161.49
0
161.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.90
0
4.90
Selling and Distribution Expenses
106.19
0
106.19
Other Expenses
1.44
0.00
1.44
Total Expenditure (Excl Depreciation)
287.03
0
287.03
Operating Profit (PBDIT) excl Other Income
137.46
0.00
137.46
Other Income
8.42
0
8.42
Operating Profit (PBDIT)
187.25
0
187.25
Interest
4.90
0
4.90
Exceptional Items
-0.44
0
-0.44
Gross Profit (PBDT)
263.00
0
263.00
Depreciation
41.55
0
41.55
Profit Before Tax
140.36
0
140.36
Tax
23.42
0
23.42
Provisions and contingencies
0
0
0.00
Profit After Tax
120.75
0
120.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
120.75
0
120.75
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.68
0
-3.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
117.07
0
117.07
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,789.34
0
2,789.34
Earnings per share (EPS)
0.63
0
0.63
Diluted Earnings per share
0.63
0
0.63
Operating Profit Margin (Excl OI)
32.34%
0%
0.00
32.34%
Gross Profit Margin
42.85%
0%
0.00
42.85%
PAT Margin
28.45%
0%
0.00
28.45%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 42.45 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 20.46% vs 6.34% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.57% vs 73.37% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.71 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 30.40% vs 8.19% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 16.29% vs 22.51% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.88 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 31.28% vs 26.11% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 17.02% vs 51.29% in Jun 2024

Quarterly - Interest
Interest 0.49 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -28.99% vs 18.97% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 16.67% vs 223.08% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.34%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024